Semaglutide Pen

5 mg per pen
Prefilled injection pen
Manufacturer: Hilma Biocare

€130.00

Description

Semaglutide Pen 5mg

The Semaglutide Pen contains a ready mixed GLP-1 receptor agonist solution. Its prefilled presentation holds 5 mg in 3 ml, distinguishing it from the lyophilized vial format.

Product specifications

Property Product information
Active substance Semaglutide
Class GLP-1 receptor agonist
Presentation Prefilled pen containing injectable solution
Total pen content 5 mg
Volume 3 ml
Indicative half life Approximately 1 week

GLP-1 signalling and satiety

Semaglutide mimics GLP-1 activity, slowing gastric emptying and reducing hunger and cravings. Its described applications include sustained weight changes through appetite and metabolic regulation, including users whose routine does not involve exercise.

  • Appetite and craving reduction
  • Slower gastric emptying
  • Blood glucose regulation
  • Sustained weight management effects

Usage and administration

The described profile includes weekly subcutaneous administration and gradual dose adjustment to limit nausea. Its numerical range of 1–3 mg per week is described in its administration context; the product content in the specifications is a separate quantity.

Related products and comparisons

The lyophilized Semaglutide vial is the other presentation in the product catalogue. Tirzepatide and Retatrutide provide the dual- and triple receptor comparisons described in its description.

Health and usage information

This page provides educational information about the product to help you make informed choices. It does not replace medical advice. If you have a health condition or questions about dosage, consult a sports medicine doctor or another healthcare professional.

Specification

Overview

Customer Reviews

Reviews

There are no reviews yet.

Be the first to review “Semaglutide Pen”

Your email address will not be published. Required fields are marked *